Literature DB >> 24307222

An efficient multistep ligand-based virtual screening approach for GPR40 agonists.

Sihui Yao1, Tao Lu, Zifan Zhou, Haichun Liu, Haoliang Yuan, Ting Ran, Shuai Lu, Yanmin Zhang, Zhipeng Ke, Jinxing Xu, Xiao Xiong, Yadong Chen.   

Abstract

G protein-coupled receptor 40/free fatty acid receptor 1 (GPR40/FFAR1) is a member of the GPCR superfamily, and GPR40 agonists have therapeutic potential for type 2 diabetes. With the crystal structure of GPR40 currently unavailable, various ligand-based virtual screening approaches can be applied to identify novel agonists of GPR40. It is known that each ligand-based method has its own advantages and limitations. To improve the efficiency of individual ligand-based methods, an efficient multistep ligand-based virtual screening approach is presented in this study, including the pharmacophore-based screening, physicochemical property filtering, protein-ligand interaction fingerprint similarity analysis, and 2D-fingerprint structural similarity search. A focused decoy library was generated and used to evaluate the efficiency of this virtual screening protocol. This multistep workflow not only significantly improved the hit rate compared with each individual ligand-based method, but also identified diverse known actives from decoys. This protocol may serve as an efficient virtual screening tool for the targets without crystal structures available to discover novel active compounds.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24307222     DOI: 10.1007/s11030-013-9493-3

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  39 in total

1.  3-Substituted 3-(4-aryloxyaryl)-propanoic acids as GPR40 agonists.

Authors:  Shawn P Walsh; Alexandra Severino; Changyou Zhou; Jiafang He; Gui-Bai Liang; Carina P Tan; Jin Cao; George J Eiermann; Ling Xu; Gino Salituro; Andrew D Howard; Sander G Mills; Lihu Yang
Journal:  Bioorg Med Chem Lett       Date:  2011-04-08       Impact factor: 2.823

Review 2.  Pharmacophore modeling and applications in drug discovery: challenges and recent advances.

Authors:  Sheng-Yong Yang
Journal:  Drug Discov Today       Date:  2010-04-01       Impact factor: 7.851

3.  ZINC--a free database of commercially available compounds for virtual screening.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Chem Inf Model       Date:  2005 Jan-Feb       Impact factor: 4.956

4.  Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.

Authors:  Nicolas Triballeau; Francine Acher; Isabelle Brabet; Jean-Philippe Pin; Hugues-Olivier Bertrand
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

5.  Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.

Authors:  Andreas Evers; Gerhard Hessler; Hans Matter; Thomas Klabunde
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

Review 6.  Similarity-based virtual screening using 2D fingerprints.

Authors:  Peter Willett
Journal:  Drug Discov Today       Date:  2006-10-20       Impact factor: 7.851

Review 7.  Fatty acid signaling in the beta-cell and insulin secretion.

Authors:  Christopher J Nolan; Murthy S R Madiraju; Viviane Delghingaro-Augusto; Marie-Line Peyot; Marc Prentki
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

8.  Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists.

Authors:  Changyou Zhou; Cheng Tang; Eric Chang; Min Ge; Songnian Lin; Eric Cline; Carina P Tan; Yue Feng; Yun-Ping Zhou; George J Eiermann; Aleksandr Petrov; Gino Salituro; Peter Meinke; Ralph Mosley; Taro E Akiyama; Monica Einstein; Sanjeev Kumar; Joel Berger; Andrew D Howard; Nancy Thornberry; Sander G Mills; Lihu Yang
Journal:  Bioorg Med Chem Lett       Date:  2009-10-15       Impact factor: 2.823

9.  Bidirectional, iterative approach to the structural delineation of the functional "chemoprint" in GPR40 for agonist recognition.

Authors:  Irina G Tikhonova; Chi Shing Sum; Susanne Neumann; Craig J Thomas; Bruce M Raaka; Stefano Costanzi; Marvin C Gershengorn
Journal:  J Med Chem       Date:  2007-06-07       Impact factor: 7.446

10.  Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.

Authors:  Michael M Mysinger; Michael Carchia; John J Irwin; Brian K Shoichet
Journal:  J Med Chem       Date:  2012-07-05       Impact factor: 7.446

View more
  3 in total

1.  Discovery of Potential Orthosteric and Allosteric Antagonists of P2Y1R from Chinese Herbs by Molecular Simulation Methods.

Authors:  Xu Zhang; Fang Lu; Yan-Kun Chen; Gang-Gang Luo; Lu-di Jiang; Lian-Sheng Qiao; Yan-Ling Zhang; Yu-Hong Xiang
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-21       Impact factor: 2.629

2.  Discovery of Potential Inhibitors of Squalene Synthase from Traditional Chinese Medicine Based on Virtual Screening and In Vitro Evaluation of Lipid-Lowering Effect.

Authors:  Yankun Chen; Xi Chen; Ganggang Luo; Xu Zhang; Fang Lu; Liansheng Qiao; Wenjing He; Gongyu Li; Yanling Zhang
Journal:  Molecules       Date:  2018-04-28       Impact factor: 4.411

Review 3.  Hierarchical virtual screening approaches in small molecule drug discovery.

Authors:  Ashutosh Kumar; Kam Y J Zhang
Journal:  Methods       Date:  2014-07-27       Impact factor: 3.608

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.